Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1
Closed -$1.04K 7266
2024
Q1
$1.04K Buy
+1
New +$1.58K ﹤0.01% 6141
2022
Q2
Sell
-2
Closed -$11K 7251
2022
Q1
$11K Hold
2
﹤0.01% 6239
2021
Q4
$26K Sell
2
-1
-33% -$12.6K ﹤0.01% 6239
2021
Q3
$35K Hold
3
﹤0.01% 5761
2021
Q2
$36K Buy
3
+2
+200% +$35.2K ﹤0.01% 5688
2021
Q1
$22K Hold
1
﹤0.01% 6119
2020
Q4
$22K Hold
1
﹤0.01% 5833
2020
Q3
$13K Buy
+1
New +$27.1K ﹤0.01% 5840
2020
Q2
Hold
0
5978
2020
Q1
Hold
0
5838
2019
Q4
Hold
0
6257

Other funds holding NCNA

Wells Fargo's NCNA Position: Q2 2024 in Review

Wells Fargo sold out of NuCana (NCNA) in Q2 2024, closing a stake of 1 share — an estimated $1.04K sold.

Wells Fargo first reported a position in NCNA in Q3 2020 and held it in 8 quarters. The position peaked at $36K in Q2 2021. 11 funds tracked by Wall St. Rank hold NCNA as of Q2 2024.

  • Wells Fargo reported no remaining NuCana position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 1 NuCana share in Q2 2024, an estimated $1.04K.
  • Wells Fargo first reported a position in NuCana in Q3 2020 and held it in 8 quarters.
  • Wells Fargo's NuCana position peaked at $36K in Q2 2021.
  • 11 funds tracked by Wall St. Rank held NuCana as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.